These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 14602869

  • 41. The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells.
    Beck C, Cayeux S, Lupton SD, Dörken B, Blankenstein T.
    Hum Gene Ther; 1995 Dec; 6(12):1525-30. PubMed ID: 8664377
    [Abstract] [Full Text] [Related]

  • 42. Antagonism of HSV-tk transfection and ganciclovir treatment on chemotherapeutic drug sensitivity.
    Van Dillen IJ, Mulder NH, Meijer C, Dam WA, Kamstra E, De Vries L, Meersma GJ, Van der Zee AG, De Vries EF, Vaalburg W, Hospers GA.
    J Chemother; 2005 Jun; 17(3):289-96. PubMed ID: 16038523
    [Abstract] [Full Text] [Related]

  • 43. Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclovir gene therapy for brain tumors.
    Hadaczek P, Mirek H, Berger MS, Bankiewicz K.
    J Neurosurg; 2005 Feb; 102(2):328-35. PubMed ID: 15739562
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX, Ngo D, Brade AM, Klamut HJ.
    Cancer Gene Ther; 1999 Feb; 6(2):179-90. PubMed ID: 10195885
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
    Benedetti S, Dimeco F, Pollo B, Cirenei N, Colombo BM, Bruzzone MG, Cattaneo E, Vescovi A, Didonato S, Colombo MP, Finocchiaro G.
    Hum Gene Ther; 1997 Jul 20; 8(11):1345-53. PubMed ID: 9295129
    [Abstract] [Full Text] [Related]

  • 49. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E, Kawano K, Hattori Y, Fukushima M, Hayashi K, Maitani Y.
    J Control Release; 2007 Jul 16; 120(1-2):104-10. PubMed ID: 17509714
    [Abstract] [Full Text] [Related]

  • 50. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
    Vincent AJ, Vogels R, Someren GV, Esandi MC, Noteboom JL, Avezaat CJ, Vecht C, Bekkum DW, Valerio D, Bout A, Hoogerbrugge PM.
    Hum Gene Ther; 1996 Jan 20; 7(2):197-205. PubMed ID: 8788170
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.
    Zhou H, He Z, Wang C, Xie T, Liu L, Liu C, Song F, Ma Y.
    Int J Mol Sci; 2016 Jun 06; 17(6):. PubMed ID: 27275821
    [Abstract] [Full Text] [Related]

  • 57. Recombinant interferon alpha2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system.
    Whartenby KA, Darnowski JW, Freeman SM, Yurasha K, Calabresi P.
    Cancer Gene Ther; 1999 Jun 06; 6(5):402-8. PubMed ID: 10505850
    [Abstract] [Full Text] [Related]

  • 58. Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line.
    Drake RR, Pitlyk K, McMasters RA, Mercer KE, Young H, Moyer MP.
    Mol Ther; 2000 Nov 06; 2(5):515-23. PubMed ID: 11082325
    [Abstract] [Full Text] [Related]

  • 59. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD.
    J Neurosci Res; 1994 Nov 01; 39(4):506-11. PubMed ID: 7884826
    [Abstract] [Full Text] [Related]

  • 60. [All-trans retinoic acid augments the bystander effect of herpes simplex virus thymidine kinase/ganciclovir system in the treatment of tongue carcinoma cell line].
    Wang AX, Huang HZ.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan 01; 38(1):24-6. PubMed ID: 12760771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.